1304 related articles for article (PubMed ID: 14656016)
1. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
2. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
3. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Clarke R; Armitage J
Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
[TBL] [Abstract][Full Text] [Related]
4. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
7. The methionine-homocysteine cycle and its effects on cognitive diseases.
Miller AL
Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
[TBL] [Abstract][Full Text] [Related]
8. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
Booth GL; Wang EE
CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
10. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
Toole JF; Malinow MR; Chambless LE; Spence JD; Pettigrew LC; Howard VJ; Sides EG; Wang CH; Stampfer M
JAMA; 2004 Feb; 291(5):565-75. PubMed ID: 14762035
[TBL] [Abstract][Full Text] [Related]
11. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
Wuillemin WA; Solenthaler M
Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
[TBL] [Abstract][Full Text] [Related]
12. Emergent cardiovascular risk factor: homocysteine.
Warren CJ
Prog Cardiovasc Nurs; 2002; 17(1):35-41. PubMed ID: 11872979
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation.
Hirsch S; Pia De la Maza M; Yañez P; Glasinovic A; Petermann M; Barrera G; Gattas V; Escobar E; Bunout D
Clin Cardiol; 2002 Nov; 25(11):495-501. PubMed ID: 12430779
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine levels in patients treated with lipid apheresis: effect of a vitamin therapy.
Julius U; Pietzsch J; Gromeier S; Schorr H; Herrmann W
Eur J Clin Invest; 2001 Aug; 31(8):667-71. PubMed ID: 11473567
[TBL] [Abstract][Full Text] [Related]
15. [Group B vitamins as new variables related to the cardiovascular risk].
Granieri M; Bellisarii FI; De Caterina R
Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
[TBL] [Abstract][Full Text] [Related]
16. [Plasma homocysteine levels in patients with ischemic heart disease].
Márk L; Erdei F; Márki-Zay J; Nagy E; Kondacs A; Katona A
Orv Hetil; 2001 Jul; 142(30):1611-5. PubMed ID: 11519232
[TBL] [Abstract][Full Text] [Related]
17. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12].
Alemán G; Tovar AR; Torres N
Rev Invest Clin; 2001; 53(2):141-51. PubMed ID: 11421110
[TBL] [Abstract][Full Text] [Related]
18. [Homocysteine--a risk factor for atherosclerosis].
Debreceni L
Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
[TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification.
Selhub J; Jacques PF; Bostom AG; Wilson PW; Rosenberg IH
Public Health Rev; 2000; 28(1-4):117-45. PubMed ID: 11411265
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine, folate, and cardiovascular disease.
Ward M
Int J Vitam Nutr Res; 2001 May; 71(3):173-8. PubMed ID: 11582839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
